Justin Joseph

Justin Joseph has a diverse work experience in the field of biomedical research. Justin is currently working as a Senior Scientist at Stipe Therapeutics, where they manage large-scale screening of peptides targeting the STING pathway in multiple cancer types. Prior to this, they worked as a Postdoctoral Scientist at Aarhus University, focusing on validating the efficacy of STING agonist and PD-1 inhibitors for combating GBM progression. Justin also has experience as a Postdoctoral Scientist at Umeå University and University of Bergen, where they worked on targeting invasive and angiogenic mechanisms in human glioblastoma. Justin completed their PhD in the role of differentiation in glioblastoma invasion at the University of Groningen and also gained research experience as a Master's Intern at IFOM and Regional Cancer Centre Thiruvananthapuram.

Justin Joseph began their education at Kendriya Vidyalaya, but no specific degree or field of study is provided for this period. Justin then went on to earn a Bachelor of Science (B.Sc.) degree in Biotechnology from Bharathiar University, which they completed from 2000 to 2003. Afterward, they pursued a Master of Science (M.Sc.) degree in Biotechnology from the same university, completing it from 2003 to 2005. Following their M.Sc., Justin enrolled at the University of Skövde, where they obtained a Master of Science (MS) degree in Molecular Biology from 2006 to 2008. Justin continued their education at the University of Groningen, earning a Doctor of Philosophy (Ph.D.) degree in Molecular Neuro-Oncology from 2009 to 2015.